Insulet Securities Fraud Class Action
Analysis based on 7 articles · First reported Aug 06, 2026 · Last updated Aug 13, 2026
The lawsuit could negatively affect Insulet's stock price and investor confidence, potentially leading to financial penalties and remediation costs. The market may react to the allegations of manufacturing defects and misleading disclosures, impacting the company's reputation and future sales.
Schall Brown & Schwartz LLP has filed a securities class action lawsuit against Insulet Corporation, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The complaint claims Insulet made false and misleading statements regarding defective manufacturing controls, which led to increased safety violation risks and a March 2026 Medical Device Correction affecting more Pod products than disclosed. The class period runs from February 21, 2025 to May 26, 2026, with a lead plaintiff deadline of August 31, 2026. Investors who purchased PODD shares during this period may be eligible for compensation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard